A Randomized, Controlled Trial of C0- Vs C2-guided Therapeutic Drug Monitoring of Cyclosporine in Stable Heart Transplant Patients

C2 monitoring allows a significant cyclosporine dose reduction without compromising patient outcome in stable heart transplant patients. Further studies are required to ascertain whether this dose reduction can be translated into clinical benefit.